Shopping Cart
- Remove All
- Your shopping cart is currently empty
GYKI-47261 dihydrochloride is an orally active and selective AMPA receptor antagonist, also a CYP2E1 inducer with broad anticonvulsant and neuroprotective activity, used in neurological and cardiovascular research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $293 | In Stock | |
5 mg | $718 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,520 | In Stock |
Description | GYKI-47261 dihydrochloride is an orally active and selective AMPA receptor antagonist, also a CYP2E1 inducer with broad anticonvulsant and neuroprotective activity, used in neurological and cardiovascular research. |
Targets&IC50 | AMPA:2.5 μM |
In vitro | GYKI-47261 dihydrochloride inhibits AMPA or rhodosine-induced whole cell currents in isolated neurons. [1] |
In vivo | GYKI-47261 dihydrochloride (200 mg/kg orally) is highly active in transient focal ischemia models. Antiischemic effect of GYKI-47261 dihydrochloride (6 mg/kg iv) in rats with transient focal cerebral ischemia. GYKI-47261 dihydrochloride effectively alleviates tremor induced by oxotremorine, a cholinergic agonist, in the treatment of Parkinson's disease. [1] |
Alias | GYKI47261 dihydrochloride |
Molecular Weight | 395.71 |
Formula | C18H17Cl3N4 |
Cas No. | 1217049-32-5 |
Smiles | ClC1=CC(C(C2=CC=C(N)C=C2)=NN3C=C(C)N=C3C4)=C4C=C1.Cl.Cl |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.